Valvular lesions in patients with systemic lupus erythematosus and antiphospholipid syndrome: An old disease but a persistent challenge

Revista Portuguesa de Cardiologia

Volumn 31, Issue 4, 2012, Pages 295-299

  Ferreira, Ester ^a,c   Bettencourt, Paulo M ^a,c   Moura, Luis M ^a,b  

^a University of Porto   (Portugal)

^b HOSPITAL PEDRO HISPANO   (Portugal)

^c HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Antiphospholipid syndrome (APS); Association; Complications; Lupus erythematosus systemic (LES); Treatment; Valvular disease

Indexed keywords

PHOSPHOLIPID ANTIBODY; PREDNISONE;

ANTIPHOSPHOLIPID SYNDROME; BACTERIAL ENDOCARDITIS; BIOPROSTHESIS; DISEASE COURSE; ECHOCARDIOGRAPHY; ENDOCARDITIS; HUMAN; PATHOGENESIS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VALVULAR HEART DISEASE;

EID: 84862771407     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repc.2012.02.005     Document Type: Short Survey

References (47)

1. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med. 1924;33:701-7.
2. Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J. 1985;110:1257-65.
3. Ansari A, Larson PH, Bates HD. Cardiovascular manifestations of systemic lupus erythematosus: current perspective. Prog Cardiovasc Dis. 1985;27:421-34.
4. D'Alton JG, Preston DN, Bormanis J, et al. Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis. Stroke. 1985;16:512-4.
5. Hughes GR. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. Br Med J. 1983;287:1088-9.
6. Hughes GR, Harris NN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol. 1986;13:486-9.
7. Harris EN. A reassessment of the antiphospholipid syndrome. J Rheumatol. 1990;17:733-5.
8. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002;346:752-63.
9. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999;42:1309-11.
10. Brigden W, Bywaters EGL, Lessof MH, et al. The heart in systemic lupus erythematosus. Br Heart J. 1960;22:1-16.
11. Farzaneh-far A, Roman MJ, Lockshin MD, et al. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Arthritis Rheum. 2006;54:3918-25.
12. Straaton K, Chatham W, Reveille J, et al. Clinically significant valvular heart disease in systemic lupus erythematosus. Am J Med. 1989;86:407-12.
13. Galve E, Candell-Riera J, Pigrau C, et al. Prevalence, morphologic types and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med. 1988;319:817-23.
14. Nihoyannopoulos P, Gomez PM, Joshi J, et al. Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation. 1990;82:369-75.
15. Khamashta MA, Cervera R, Asherson R, et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet. 1990;335:1541-4.
16. Cervera R, Font J, Pare C, et al. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis. 1992;51:156-9.
17. Jouhikainen T, Pohjola-Sintonen S, Stephansson E. Lupus anticoagulant and cardiac manifestations in systemic lupus erythematosus. Lupus. 1994;3:167-72.
18. Vianna JL, Khamashta MA, Ordi-Ros J, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med. 1994;96:3-9.
19. Roldan CA, Shively BK, Lau CC, et al. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol. 1992;20:1127-34.
20. Perez-Villa F, Font J, Azqueta M, et al. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, follow-up study. Arthritis Rheum (Arthritis Care Res). 2005;53:460-7.
21. Moyssakis I, Tektonidou MG, Vasilliou VA, et al. Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med. 2007;120:636-42.
22. Hojnik M, George J, Ziporen L, et al. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation. 1996;93:1579-87.
23. Ford SE, Charrette EJ, Knight J, et al. A possible role for antiphospholipid antibodies in acquired cardiac valve deformity. J Rheumatol. 1990;17:1499-503.
24. Ziporen L, Goldberg I, Arad M, et al. Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus. 1996;5:196-205.
25. Asherson RA, Hughes GR. The expanding spectrum of Libman Sacks endocarditis: the role of antiphospholipid antibodies. Clin Exp Rheumatol. 1989;7:225-8.
26. Roberts WC, High ST. The heart in systemic lupus erythematosus. Curr Probl Cardiol. 1999;24:1-56.
27. Roldan CA. Valvular disease associated with systemic illness. Cardiol Clin. 1998;16:531.
28. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633-8.
29. Menard GE. Establishing the diagnosis of Libman-Sacks endocarditis in systemic lupus erythematosus. J Gen Intern Med. 2008;23:883-6.
30. Lee JL, Naguwa SM, Cheema GS, et al. Revisiting Libman-Sacks endocarditis: a historical review and update. Clin Rev Allergy Immunol. 2009;36:126-30.
31. Asherson R, Cervera R. Antiphospholipid antibodies and the heart. Circulation. 1991;84:920-2.
32. Mottram PM, Gelman JS. Mitral valve thrombus mimicking a primary tumor in the antiphospholipid syndrome. J Am Soc Echocardiogr. 2002;15:746-8.
33. Taguchi S, Hashimoto K, Sakamoto Y, et al. A case of mitral valve plasty for Libman-Sacks endocarditis mimicking a cardiac tumor. J Thorac Cardiovasc Surg. 2006;132:1465-7.
34. Appelbe AF, Olson D, Mixon R, et al. Libman-Sacks endocarditis mimicking intracardiac tumor. Am J Cardiol. 1991;68:817-8.
35. Bouma W, Klinkenberg TJ, van der Horst IC, et al. Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature. J Cardiothorac Surg. 2010;5:13.
36. Lopez JA, Fishbein MC, Siegel RJ. Echocardiographic features of nonbacterial thrombotic endocarditis. Am J Cardiol. 1987;59:478-80.
37. Roldan CA, Quails CR, Sopko KS, et al. Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study. J Rheumatol. 2008;35:224-9.
38. Feigenbaum H, Armstrong WF, Ryan T. Feigenbaum's echocardiography. Philadelphia: Lippincott Williams and Wilkins; 2005. p. 375-81.
39. Morin AM, Boyer AS, Nataf P, et al. Mitral insufficiency caused by systemic lupus erythematosus requiring valve replacement: three case reports and a review of the literature. Thorac Cardiovasc Surg. 1996;44:313-6.
40. Bulkey BH, Roberts WC. Systemic lupus erythematosus as a cause of severe mitral regurgitation. New problem in an old disease. Am J Cardiol. 1975;35:305-8.
41. Colli A, Mestres CA, Espinosa G, et al. Heart valve surgery in patients with the antiphospholipid syndrome: analysis of a series of nine cases. Eur J Cardiothorac Surg. 2010;37:154-8.
42. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996;335:1424-30.
43. Nesher G, Ilany J, Rosenmann D, et al. Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment. Semin Arthritis Rheum. 1997;27:27-35.
44. Hakim JP, Mehta A, Jain AC, et al. Mitral valve replacement and repair. Report of 5 patients with systemic lupus erythematosus. Tex Heart Inst J. 2001;28:47-52.
45. Lockhart PB, Loven B, Brennan MT, et al. The evidence base for the efficacy of antibiotic prophylaxis in dental practice. JAMA. 2007;138:458-74.
46. Dória A, Iaccarino L, Sarzi-Puttini P, et al. Cardiac involvement in systemic lupus erythematosus. Lupus. 2005;14:683-6.
47. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis. New version 2009. Eur Heart J. 2009;30:2369-413.